Autor: |
Mohammadi, Mohsen, mojaveri, Parisa Ebrahimzade, Sadeghi, Farzin, Pournajaf, Abazar, Mir, Ali Mohammadpour, Esfandiar, Hanie, Najafi, Rahmatollah |
Předmět: |
|
Zdroj: |
Current Research in Medical Sciences; 2022, Vol. 6 Issue 1, p10-14, 5p |
Abstrakt: |
Background and Objective: Variant Omicron was discovered as a newest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first emergence of the omicron variant was detected in November 2021. In this study, we investigated the clinical manifestation, laboratory and radiological findings and responding to treatment of 70 pediatric patients with positive RTPCR COVID-19 in Omicron peak. We described 20 criteria associated with efficacy, such as demographic data, clinical manifestation, laboratory and radiological findings. All of the patients received Remdesivir that 5.7% of patients responded to the treatment. No patients were given Intravenous Immunoglobulin (IVIG). This is the first study aimed at assessing symptoms clinical manifestation among hospitalization pediatrics patients in pediatric Hospital of Amir kola, Babol. The findings of this study can be effective in preventing and controlling disease transmission among children. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|